Chat with us, powered by LiveChat

Acne Medication Market

Acne Medication Market : Segmented by Formulation (Topical, Oral); By Product (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid, Others); By Type (Prescription, OTC); By Acne Type (Inflammatory Acne, Non-Inflammatory Acne); By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, E-commerce) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Published on: Aug-2021
Report Code: FG HC 00880
No. of Pages: 170-350
Report Format: PDF

[170+ Pages Research Report] Acne Medication market to surpass USD 14.68 billion by 2030 from USD 8.6 billion in 2020 at a CAGR of 5.49% in the coming years, i.e., 2021-30.

Product Overview

Acne vulgaris, often known as acne, is a common skin condition that occurs when the hair follicles get clogged as a result of excessive oil production, debris, and dead skin cells. Pimples, whiteheads, blackheads, and scars may accompany it. Inflammatory and non-inflammatory acne are the two forms of acne that exist. Acne therapy involves utilizing drugs and medications to remove dead skin cells, reduce sebum output, and eliminate germs.

Market Highlights

Acne Medication market is expected to project a notable CAGR of 5.49% in 2030

Acne medication market expansion is being fueled by an increase in the global occurrence of acne diseases. Teenagers' adoption of unhealthy lifestyles and growing acceptance of skincare products are two major reasons driving market growth. The availability and emergence of a wide range of products containing antibiotic agents, such as lotions, creams, and gels, as well as the additional advantages associated with their usage, would boost demand for acne medication.

Recent highlights in the Acne Medication Market

  • In April 2021, Acelity, In South Korea, Galderma announced the launch of Aklief, an acne treatment medication. This medication targets the retinoid receptor gamma in the retinoic acid receptor (RAR) in the skin, making acne therapy more efficient and effective. This strategic decision will help the corporation grow its operations in South Korea.

  • In January 2021, Eligo Bioscience and GlaxoSmithKline have formed a research collaboration. Eligobiotics' acne vulgaris therapy uses cutting-edge CRISPR-based therapeutic technology. This strategic partnership is anticipated to speed up research and development operations, giving the firm a competitive advantage.

Acne Medication Market: Segments

segment to grow with the highest CAGR during 2020-30

Acne Medication market is segmented by Formulation into Topical and Oral. Among these, the Topical category is expected to hold the highest CAGR in the forecast period. This is because retinoids, BPO, azelaic acid, antibiotics, and salicylic acid are used topically for acne maintenance and mild to severe acne.

Retinoids segment to grow with the highest CAGR during 2020-30

Acne Medication market is segmented by Product into Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid, and Others. Among these, the Retinoids category had the highest revenue share of more than 27% in 2020. The microcomedo–precursor lesion of acne is where the focus of topical retinoids is on. Based on the severity of acne, retinoids are typically used as a first-line treatment, either alone or in combination with other medications. They're commonly used to treat severe inflammatory acne, and they're also a popular choice for maintenance therapy. Retinoids also decrease microcomedones and follicular obstruction in both non-inflammatory and inflammatory acne. As a result of their higher efficacy and compatibility when coupled with other medicines, retinoids are expected to propel the market forward throughout the projected period.

Market Dynamics


Growing awareness regarding the treatment options and advancements

The industry will grow in the coming years due to rising awareness of therapeutics in acne treatment and the increasing incidence of acne disorders in the many regions due to climate change. However, as a result of continuous advancements, increased knowledge of acne medication choices such as dermo-cosmetics, biologics, and complementary and alternative medicines (CAM) has boosted product acceptance across the globe. Several CAM therapies have been marketed as acne treatments as a result of research and development activities, and are generally considered safe.

Increasing disposable income of consumers

Because of the rising demand and adoption rate of acne medicine, a rise in consumer disposable income is expected to enhance the market for acne medication. Acne treatments are used to treat acne that is mild to severe and can result in deformity. Acne is a skin disease that affects the oil glands on certain skin surfaces. Growing public concern about their physical appearance is expected to fuel the expansion of the acne medicine industry. The expansion of the acne medicine market is being driven by rising instances of acne as a result of modern patients' lifestyles and its high prevalence among teenagers.


Increased risk of side effects and blood clots

Topical acne medicines cause skin dryness, whereas oral acne medications cause dizziness and lightheadedness, as well as increasing the risk of blood clots in people with high blood pressure. The presence of alternative treatments such as laser therapy is also expected to restrain market expansion.

Acne Medication Market: Key Players

  • Allergan Plc

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

  • Glaxosmithkline Plc
  • Johnson Johnson
  • Mayne Pharma Group Limited
  • Mylan N V
  • Nestle S A
  • Pfizer Inc
  • Sun Pharma
  • Teva Pharmaceutical Industry Ltd
  • Valeant Pharmaceutical International

Acne Medication Market: Regions

Acne Medication market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, and the Middle East, and Africa. Acne Medication market in North America held the largest market share in the year 2019 as a result of significant advancements in acne treatment. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period, due to an increase in the number of product launches, high demand for acne therapeutics, and an increase in healthcare expenditure, as well as increased awareness of newly developed therapeutics that can replace conventional acne treatment.

Acne Medication Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – China, Japan, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Acne Medication Market report also contains analysis on:

Acne Medication Market Segments:

  • By Formulation
    • Topical
    • Oral
  • By Product
    • Retinoids
    • Antibiotics
    • Salicylic Acid
    • Benzoyl Peroxide
    • Azelaic Acid
    • Others
  • By Type
    • Prescription
    • OTC
  • By Acne Type
    • Inflammatory Acne
    • Non-Inflammatory Acne
  • By Distribution Channel
    • Retail Stores
    • Pharmacies & Drug Stores
    • E-commerce
  • Acne Medication Market Dynamics
  • Acne Medication Market Size
  • Supply & Demand
  • Current Market Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Acne Medication Market Report Scope and Segmentation

Select License Type


Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555

Select License Type


Report accessible by 1 user only

Sample Request

Client Testimonials